Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Cannon

Showing results (41-50 of 149) with videos related to

Pageof 15
Sort By:
Journal of the American College of Cardiology|November 15, 1995
Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II InvestigatorsC Hall, C P Cannon, S Forman, et al.
Clinical Cardiology|February 4, 1999
The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery diseaseM J Tanasijevic, C P Cannon, E M Antman
Clinical Cardiology|September 24, 1999
Prehospital thrombolysis: an idea whose time has comeC P Cannon, A J Sayah, R M Walls
The Journal of Emergency Medicine|October 26, 2000
ER TIMI-19: testing the reality of prehospital thrombolysisC P Cannon, A J Sayah, R M Walls
The American Journal of Geriatric Cardiology|May 22, 2001
Ischemic preconditioning: implications for the geriatric heartR A Kloner, T Shook, C P Cannon, et al.
Journal of Interventional Cardiology|March 9, 1995
The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decadeC P Cannon, E Braunwald, C H McCabe, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2010
Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patientsL Laine, S P Curtis, B Cryer, et al.
Circulation|February 2, 2000
Critical pathways : a review. Committee on Acute Cardiac Care, Council on Clinical Cardiology, American Heart AssociationN R Every, J Hochman, R Becker, et al.
The American Journal of Cardiology|March 23, 2000
Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial InfarctionM B Holmes, B E Sobel, C P Cannon, et al.
Archives of Internal Medicine|July 11, 1994
Use of a standardized heparin nomogram to achieve therapeutic anticoagulation after thrombolytic therapy in myocardial infarction. TIMI 4 investigators. Thrombolysis in Myocardial InfarctionG C Flaker, J Bartolozzi, V Davis, et al.
Pageof 15

Showing results (41-50 of 149) with videos related to

Sort By:
Pageof 15
Journal of the American College of Cardiology|November 15, 1995
Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II InvestigatorsC Hall, C P Cannon, S Forman, et al.
Clinical Cardiology|February 4, 1999
The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery diseaseM J Tanasijevic, C P Cannon, E M Antman
Clinical Cardiology|September 24, 1999
Prehospital thrombolysis: an idea whose time has comeC P Cannon, A J Sayah, R M Walls
The Journal of Emergency Medicine|October 26, 2000
ER TIMI-19: testing the reality of prehospital thrombolysisC P Cannon, A J Sayah, R M Walls
The American Journal of Geriatric Cardiology|May 22, 2001
Ischemic preconditioning: implications for the geriatric heartR A Kloner, T Shook, C P Cannon, et al.
Journal of Interventional Cardiology|March 9, 1995
The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decadeC P Cannon, E Braunwald, C H McCabe, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2010
Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patientsL Laine, S P Curtis, B Cryer, et al.
Circulation|February 2, 2000
Critical pathways : a review. Committee on Acute Cardiac Care, Council on Clinical Cardiology, American Heart AssociationN R Every, J Hochman, R Becker, et al.
The American Journal of Cardiology|March 23, 2000
Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial InfarctionM B Holmes, B E Sobel, C P Cannon, et al.
Archives of Internal Medicine|July 11, 1994
Use of a standardized heparin nomogram to achieve therapeutic anticoagulation after thrombolytic therapy in myocardial infarction. TIMI 4 investigators. Thrombolysis in Myocardial InfarctionG C Flaker, J Bartolozzi, V Davis, et al.
Pageof 15